Swaraj Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 18-12-2024
- Paid Up Capital ₹ 4.00 M
as on 18-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.65 Cr
as on 18-12-2024
- Revenue -25.95%
(FY 2023)
- Profit -15.15%
(FY 2023)
- Ebitda 36.26%
(FY 2023)
- Net Worth 197.51%
(FY 2023)
- Total Assets 9.14%
(FY 2023)
About Swaraj Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.65 Cr.
Manisha Sambhaji, Swaraj Yadav, and Swarangi Yadav serve as directors at the Company.
- CIN/LLPIN
U73200MH2020PTC339795
- Company No.
339795
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2020
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Swaraj Lifesciences?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Swaraj Yadav | Director | 17-May-2020 | Current |
Manisha Sambhaji | Director | 17-May-2020 | Current |
Swarangi Yadav | Director | 07-Nov-2020 | Current |
Financial Performance of Swaraj Lifesciences.
Swaraj Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.95% decrease. The company also saw a substantial fall in profitability, with a 15.15% decrease in profit. The company's net worth Soared by an impressive increase of 197.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Swaraj Lifesciences?
Unlock access to Swaraj Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Enrich Agro Tech Producer Company LimitedActive 8 years 3 months
Manisha Sambhaji is a mutual person
- Symps Technology Solutions Private LimitedActive 1 month 16 days
Manisha Sambhaji is a mutual person
- Shivputra Sambhaji Milk Producer AssociationActive 10 months 13 days
Manisha Sambhaji and Swarangi Yadav are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 24 Feb 2022 | ₹1.25 Cr | Open |
Others Creation Date: 27 Oct 2021 | ₹4.00 M | Open |
How Many Employees Work at Swaraj Lifesciences?
Swaraj Lifesciences has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Swaraj Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swaraj Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.